Although multiple studies have shown FBN1 mutations as the cause of Marfan syndrome (MFS), which is further associated with increased risk of tumourigenesis (27), very little is known about the role of FBN1 mutations in cancer. This evidence concerns the gene FBN1 and Marfan syndrome.